Medical Devices & Pharma Articles
The top healthcare stories this week include Lidl GB's diet warning, Sanofi's executive reshuffle, GSK's UK commitment and NVIDIA's surgical robotics leap
Johnson & Johnson is hoping it can improve treatment outcomes for one of oncology’s toughest challenges after confirming the acquisition of Firefly Bio
GE HealthCare beat Q2 expectations and reaffirmed guidance as its finance operations enter a new chapter after announcing the departure of CFO Jay Saccaro
GSK’s investment includes a specialist research hub in Cambridge, UK as it seeks to advance late-stage clinical pipeline development under CEO Luke Miels
Sanofi’s revamped executive team brings leaders from across the company’s key global functions to support its “next strategic chapter” and future growth
Eli Lilly has agreed to purchase biopharmaceutical company AtaiBeckley, which is developing psychedelic-based therapies for treatment-resistant depression
Johnson & Johnson’s 2026 Q2 earnings report demonstrates strong sales growth, with the company now on track for record-breaking annual revenue performance
PwC calls for targeted investment in women’s oncology, highlighting funding disparities, advances in precision medicine and the need for earlier diagnosis